Table 1.
Respondent characteristics
| Had already reviewed | BMJ (n=122) |
RIE
(n=35) |
All (n=157) |
| Median (LQ, UQ) number of reviews completed | 2 (1, 4) | 2 (1, 3) | 2 (1, 4) |
| Country of residence, n (%) | |||
| UK | 63 (52) | 28 (80) | 91 (58) |
| Europe (excluding UK) | 20 (16) | 3 (9) | 23 (15) |
| North America | 36 (30) | 2 (6) | 38 (24) |
| Australia/New Zealand | 3 (2) | 2 (6) | 5 (3) |
| Median (LQ, UQ) number of days per month spent on patient involvement and engagement activities | 5 (2, 11) | 11 (3, 24) | 5 (2, 15) |
| Had not already reviewed |
BMJ
(n=51) |
RIE
(n=16) |
All (n=67) |
| Country of residence, n (%) | |||
| UK | 22 (43) | 5 (31) | 27 (40) |
| Europe (excluding UK) | 10 (20) | 10 (63) | 20 (30) |
| North America | 14 (27) | 0 (0) | 14 (21) |
| Australia/New Zealand | 0 (0) | 0 (0) | 0 (0) |
| Asia | 1 (2) | 0 (0) | 1 (1) |
| Median (LQ, UQ) number of days per month spent on patient involvement and engagement activities | 6 (2, 14) | 21 (10, 26) | 7 (3, 21) |
Percentages do not sum to 100% because of missing data.
LQ, lower quartile; RIE, Research Involvement and Engagement; UQ, upper quartile.